BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Instructions to Utilize Your Brain science Certification to Work on Corporate Culture - 2Top 15 Supportable Design Brands Coming out on top
- 3Figuring out the Business venture Code: The Response to Building an Effective Startup
- 4Australia Cracks Down on Gambling Ads as Prediction Markets Like Polymarket Remain Blocked
- 5NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- ‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- The Electric Toyota Hilux Is Finally here, But It's Not Cheap
- Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- Nine in 10 German industrial firms expect Iran war to hit business
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- More people are addicted to marijuana, but fewer of them are seeking help, experts say
- Astrophotographer captures rare footage of the Hubble Telescope crossing the sun (video)
- Manual for Financial plan Agreeable PC
